v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (2,059,028) $ (7,148,459)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation 20,783
Asset impairment loss 402,746
Change in fair value of derivative financial instruments—warrants 53,142 4,102,408
Changes in operating assets and liabilities:    
Accounts payable and accrued expenses 247,442 (22,693)
Prepaid expenses and other assets 943,073 152,433
Net cash used in operating activities (815,371) (2,492,782)
Cash flows from investing activities:    
Investment in license agreement (132,117)
Net cash used in investing activities (132,117)
Cash flows from financing activities:    
Proceeds from the issuance of common stock and warrants, net 700,000 9,000,000
Equity issuance costs (30,000) (802,597)
Payments on notes payable (54,066) (3,054,517)
Net cash provided by financing activities 615,934 5,142,886
Net increase (decrease) in cash (199,437) 2,517,987
Cash at beginning of period 1,828,062 406,408
Cash at end of period 1,628,625 2,924,395
Supplementary disclosure of non-cash financing activities:    
Issuance of Note Payable for payment of prepaid expense 526,178
Cashless Exercise of 2025 Series B Warrants 10,430,732
Issuance of common stock in connection with license agreement $ 270,629